Product image of Iremofar (Hydroxyzine Hydrochloride) supplied by GNH India

Iremofar

Active Ingredient:
Hydroxyzine Hydrochloride
Origin:
EU

Iremofar (Hydroxyzine Hydrochloride)

Hydroxyzine Hydrochloride, the active ingredient in Iremofar, is an antihistamine presented as a topical formulation for skin application. It works to relieve itching and allergic skin irritation in adults and children when prescribed by a healthcare professional.

GNH India supplies Iremofar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Hydroxyzine Hydrochloride is an antihistamine that acts on skin‑related allergic pathways to reduce itching and inflammation.

  • Pruritus: provides relief from itching associated with various dermatologic conditions.
  • Allergic skin reactions: alleviates redness, swelling and discomfort caused by allergic contact dermatitis.
  • Atopic dermatitis flare‑ups: helps control itch and secondary skin irritation during flare periods.

How It Works

  • Hydroxyzine Hydrochloride selectively blocks peripheral histamine H1 receptors, preventing histamine‑mediated activation of sensory nerves in the skin. This antagonism reduces the release of inflammatory mediators, leading to decreased itching and skin irritation. The compound also exhibits mild anticholinergic and sedative activity that may contribute to overall symptom relief when applied topically.

Side Effects

Hydroxyzine Hydrochloride applied to the skin may cause a range of local and systemic reactions.

Common Side Effects

  • Local skin irritation: mild redness or itching at the application site.
  • Dryness: temporary loss of skin moisture.
  • Burning sensation: transient warmth or stinging.
  • Erythema: slight reddening of the skin.
  • Pruritus worsening: paradoxical increase in itching in rare cases.

Serious or Rare Side Effects

  • Allergic contact dermatitis: severe rash, swelling or blistering.
  • Systemic antihistamine toxicity: drowsiness, dizziness, tachycardia if absorbed in large amounts.
  • Anaphylaxis: rapid onset of breathing difficulty, swelling of face or throat.
  • Severe skin necrosis: localized tissue death requiring medical attention.
  • Hypotension: unusually low blood pressure after extensive absorption.

Precautions & Warnings

When using Iremofar, consider the following safety measures.

  • Pediatric use: apply only under professional supervision and according to prescribed amount.
  • Broken skin: avoid application on open wounds or severely damaged skin.
  • Concomitant topical antihistamines: do not layer multiple antihistamine products without guidance.
  • Glaucoma patients: use with caution due to potential anticholinergic effects.
  • Pregnancy and lactation: safety not established; consult a healthcare provider before use.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Hydroxyzine Hydrochloride may interact with other medicines when absorbed systemically.

Major Interactions (Avoid)

  • Systemic antihistamines: risk of additive sedation and anticholinergic load.
  • CNS depressants (e.g., benzodiazepines, opioids): may enhance drowsiness.
  • Alcohol: can increase sedative effects.
  • Anticholinergic drugs (e.g., atropine): may intensify anticholinergic side effects.
  • QT‑prolonging agents: potential for cardiac rhythm disturbances.

Moderate Interactions (Monitor Closely)

  • Topical corticosteroids: may increase hydroxyzine absorption.
  • CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): could raise systemic levels if significant skin penetration occurs.

Frequently Asked Questions

Iremofar contains hydroxyzine hydrochloride and is applied to the skin to relieve itching (pruritus) and reduce irritation from allergic skin reactions such as contact dermatitis. It is intended for short‑term use under the direction of a healthcare professional.

Hydroxyzine hydrochloride blocks peripheral H1 histamine receptors on skin cells, preventing histamine‑driven nerve activation and inflammation. This reduces the sensation of itch and the redness associated with allergic skin responses.

The exact amount and frequency of Iremofar application are determined by the prescribing clinician based on the patient’s age, condition severity, and treatment response. Patients should follow the healthcare provider’s instructions precisely.

Safety data for topical hydroxyzine during pregnancy or lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Iremofar.

To request Iremofar, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Iremofar’s active ingredient, hydroxyzine hydrochloride, offers both antihistamine and mild sedative properties, which can be advantageous for severe itching. Compared with non‑sedating antihistamine creams, it may provide faster itch relief but may also carry a higher risk of systemic sedation if absorbed.

Store Iremofar at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture, heat and direct sunlight to maintain product stability.

Apply a thin layer of Iremofar to the affected skin area as directed by a healthcare professional, usually 1–2 times daily. Gently rub until the product is absorbed, and wash hands after application to avoid accidental contact with eyes or mucous membranes.

Serious risks include allergic contact dermatitis, systemic antihistamine toxicity leading to excessive drowsiness or cardiac effects, and rare cases of anaphylaxis. If any severe reaction occurs, discontinue use and seek immediate medical attention.

Iremofar should not be used by individuals with known hypersensitivity to hydroxyzine or any excipients in the formulation, on severely broken skin, or by patients with conditions that could be worsened by anticholinergic effects, such as uncontrolled glaucoma, without medical advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.